Rockwell Medical Inc - Asset Resilience Ratio
Rockwell Medical Inc (RMTI) has an Asset Resilience Ratio of 24.87% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Rockwell Medical Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Rockwell Medical Inc's Asset Resilience Ratio has changed over time. See Rockwell Medical Inc balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Rockwell Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Rockwell Medical Inc (RMTI) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $14.28 Million | 24.87% |
| Total Liquid Assets | $14.28 Million | 24.87% |
Asset Resilience Insights
- Good Liquidity Position: Rockwell Medical Inc maintains a healthy 24.87% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Rockwell Medical Inc Industry Peers by Asset Resilience Ratio
Compare Rockwell Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Huadong Medicine Co Ltd
SHE:000963 |
Drug Manufacturers - Specialty & Generic | 0.05% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
Drug Manufacturers - Specialty & Generic | -2.56% |
|
Celltrion Pharm Inc
KQ:068760 |
Drug Manufacturers - Specialty & Generic | 12.49% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
Annual Asset Resilience Ratio for Rockwell Medical Inc (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Rockwell Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 25.00% | $14.29 Million | $57.15 Million | +14.97pp |
| 2024-12-31 | 10.03% | $5.94 Million | $59.21 Million | +6.29pp |
| 2023-12-31 | 3.74% | $1.95 Million | $52.17 Million | -20.68pp |
| 2022-12-31 | 24.42% | $11.39 Million | $46.63 Million | +5.57pp |
| 2021-12-31 | 18.85% | $9.16 Million | $48.57 Million | +6.00pp |
| 2020-12-31 | 12.86% | $10.00 Million | $77.75 Million | -19.30pp |
| 2019-12-31 | 32.15% | $14.25 Million | $44.32 Million | +11.57pp |
| 2018-12-31 | 20.58% | $10.82 Million | $52.56 Million | -21.35pp |
| 2017-12-31 | 41.93% | $24.65 Million | $58.78 Million | -7.08pp |
| 2016-12-31 | 49.02% | $40.76 Million | $83.15 Million | +4.06pp |
| 2015-12-31 | 44.96% | $39.48 Million | $87.82 Million | +24.62pp |
| 2014-12-31 | 20.33% | $19.93 Million | $98.00 Million | -12.76pp |
| 2013-12-31 | 33.10% | $12.03 Million | $36.36 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.03 Million | -- |
| 2011-12-31 | 36.98% | $11.81 Million | $31.94 Million | +4.68pp |
| 2010-12-31 | 32.29% | $11.94 Million | $36.97 Million | +32.18pp |
| 2004-12-31 | 0.12% | $9.00K | $7.70 Million | -0.01pp |
| 2003-12-31 | 0.13% | $9.00K | $7.04 Million | -0.09pp |
| 2002-12-31 | 0.22% | $14.00K | $6.45 Million | -4.62pp |
| 2001-12-31 | 4.84% | $293.00K | $6.06 Million | +1.13pp |
| 2000-12-31 | 3.70% | $150.00K | $4.05 Million | -- |
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more